Certified Global Research Member

Key Questions Answered

Global Market Outlook
In-depth analysis of global and regional trends
Analyze and identify the major players in the market, their market share, key developments, etc.
To understand the capability of the major players based on products offered, financials, and strategies.
Identify disrupting products, companies, and trends.
To identify opportunities in the market.
Analyze the key challenges in the market.
Analyze the regional penetration of players, products, and services in the market.
Comparison of major playersâ€™ financial performance.
Evaluate strategies adopted by major players.
Recommendations

Why Choose Market Research Future?

Vigorous research methodologies for specific market.
Knowledge partners across the globe
Large network of partner consultants.
Ever-increasing/ Escalating data base with quarterly monitoring of various markets
Trusted by fortune 500 companies/startups/ universities/organizations
Large database of 5000+ markets reports.
Effective and prompt pre- and post-sales support.

Atopic Dermatitis Companies

In the dermatology sector, Atopic Dermatitis companies concentrate on developing advanced solutions for managing and treating this chronic skin condition. These companies contribute to improving the quality of life for individuals affected by atopic dermatitis.

atopic dermatitis market

Latest Atopic Dermatitis Companies Updates:

Dermavant Sciences receives U.S. Food and Drug Administration (FDA) approval for Vtama (tapinarof) cream for moderate-to-severe plaque psoriasis: This October 2023 development could potentially offer future opportunities for Vtama as a potential treatment option for atopic dermatitis, given its mechanism of action.

AbbVie announces positive Phase 3 results for upadacitinib in treating moderate-to-severe atopic dermatitis: This September 2023 update indicates potential for this JAK inhibitor to offer another effective treatment option for patients with atopic dermatitis.

Eli Lilly receives US regulatory approval for lebrikizumab for moderate-to-severe atopic dermatitis: This August 2023 milestone expands the availability of IL-13 inhibitor therapies for managing atopic dermatitis.

GlaxoSmithKline (GSK) releases the GALVANIZE study results suggesting positive outcomes for dupilumab (Dupixent) in treating chronic hand eczema associated with atopic dermatitis: This September 2023 research opens up a potential wider application of existing therapies for specific manifestations of atopic dermatitis.

Almirall launches Ekstar™ (calcipotriol/betamethasone dipropionate) foam in the US for the treatment of plaque psoriasis: While intended for psoriasis, this October 2023 launch might offer insights into potential future developments of foam-based formulations for atopic dermatitis treatment.

List of Atopic Dermatitis Key companies in the market:

Astellas Pharma Inc. (Japan)

Sanofi S.A. (France)

Anacor Pharmaceuticals Inc. (U.S)

Novartis International AG (Switzerland)

Bristol-Myers Squibb (U.S)

Meda Pharmaceuticals (U.S)

Pfizer Inc. (U.S)

Atopic Dermatitis Companies

Leading companies partner with us for data-driven Insights

Kindly complete the form below to receive a free sample of this Report

Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
	Single User	$ 4,950
	Multiuser License	$ 5,950
	Enterprise User	$ 7,250
Compare Licenses

Tailored for You

Dedicated Research on any specifics segment or region.
Focused Research on specific players in the market.
Custom Report based only on your requirements.
Flexibility to add or subtract any chapter in the study.
Historic data from 2014 and forecasts outlook till 2040.
Flexibility of providing data/insights in formats (PDF, PPT, Excel).
Provide cross segmentation in applicable scenario/markets.